Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1583)	9/6/2000 9:05:28 PM
From: JMarcus	Respond to of 52153

CORX rocketed up 35.42% today. Dr. Harry Tracy posted the following explanation of today's move on the Ragingbull thread at ragingbull.altavista.com >>With the rest of the neuro sector down today (with a couple of minor exceptions) and Cortex up almost 40%, this is no technical adjustment. Back at the end of June, in the July NI, I said the dementia/MCI deal should be done "in the next two to three months." With Europe back from August vacation, someone (or several) is buying heavily in anticipation of a deal which I expect to be announced imminently. And this will be the 'outside the US' aspect of what is Cortex's core asset--Ampakines for cognitive decline. Schizophrenia and depression were serendipitous sideline additions. But this is what Cortex, and its shareholders, have been awaiting for years. NeuroInvestment (www.neuroinvestment.com)<<